The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 44%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
San Juan Basin Royalty Trust
SJT · the NYSE · USD · Market cap $126M
San Juan Basin Royalty Trust operates as an express trust in Texas.
Not yet scoredAt the last full screen
2025-12-31
Screened 2025-12-31 · the tape above runs as of 00:54 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
San Juan Basin Royalty Trust holds its Markup at $2.70. The statistical read favours the sellers, held for 4 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 4 days |
| Price at the screen | $2.70 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.58 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.36% | Below 33% | Interest-bearing debt is just 14.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.86% | Below 49% | Money owed to the company is 0.9% of assets, under the 49% limit. | Pass |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| EPS, trailing | -0.02 |
| Revenue growth | -97.6%revenue is shrinking |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -32.6%not currently earning a positive return on equity |
| Debt to equity | 0.39minimal debt: a conservative balance sheet |
| Beta | 0.58steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 2.57 - 6.61 |
| Moat | NONE |
| Market cap | $126M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSJT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 18.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 44%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 44%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.43 | -19.6% | · | $804 | -19.6% |
| 2 months | $4.54 | -21.6% | · | $784 | -21.6% |
| 3 months | $5.02 | -29.1% | · | $709 | -29.1% |
| 6 months | $5.85 | -39.2% | · | $609 | -39.2% |
| 1 year | $6.38 | -44.2% | · | $558 | -44.2% |
| 2 years | $4.03 | -11.7% | · | $883 | -11.7% |
| 3 years | $8.03 | -55.7% | $0.29 | $480 | -52.0% |
| 5 years | $3.92 | -9.1% | $3.35 | $1,765 | +76.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SJT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.